Bowel Interest Group
  • HOME
  • ABOUT
    • MEET THE BOARD
    • CONTACT
  • WEBINARS
  • NEWS
  • RESOURCES
  • SUBSCRIBE
Select Page

News

Join our mailing list to receive our quarterly email newsletter with news, updates and events in bowel management.

SUBSCRIBE
  • All
  • Cancer
  • Coeliac Disease
  • Constipation
  • Incontinence
  • IBS
  • Inflammatory Bowel Disease
  • Paediatrics
  • Crohn's Disease
Guts UK raises concern over increase in microscopic colitis cases

Guts UK raises concern over increase in microscopic colitis cases

April 17, 2023
NICE updates its Medical Technologies Guidance 36 on Peristeen® Plus

NICE updates its Medical Technologies Guidance 36 on Peristeen® Plus

February 24, 2023
Rinvoq shown an effective in treating crohn’s & ulcerative colitis

Rinvoq shown an effective in treating crohn’s & ulcerative colitis

November 17, 2022
NICE publishes final draft guidance on ozanimod

NICE publishes final draft guidance on ozanimod

September 8, 2022
MHRA approves RINVOQ®▼ (upadacitinib) for the treatment of ulcerative colitis

MHRA approves RINVOQ®▼ (upadacitinib) for the treatment of ulcerative colitis

August 18, 2022
Enterome & Nestlé collaborate on immunotherapies for inflammatory bowel disease and food allergies

Enterome & Nestlé collaborate on immunotherapies for inflammatory bowel disease and food allergies

July 18, 2022
Ustekinumab and adalimumab showed high rates of remission for Crohn’s in SEAVUE study

Ustekinumab and adalimumab showed high rates of remission for Crohn’s in SEAVUE study

June 21, 2022
NHS Scotland approve JYSELECA®▼ (filgotinib) for Ulcerative Colitis (UC)

NHS Scotland approve JYSELECA®▼ (filgotinib) for Ulcerative Colitis (UC)

May 9, 2022
MHRA grants early access to AbbVie’s treatment for Crohn’s Disease

MHRA grants early access to AbbVie’s treatment for Crohn’s Disease

April 21, 2022
Implantica announces launch of RefluxStop™ in UK

Implantica announces launch of RefluxStop™ in UK

March 29, 2022
Guts UK Irritable Bowel Syndrome Survey

Guts UK Irritable Bowel Syndrome Survey

March 10, 2022
New therapeutic options for childhood inflammatory bowel disease

New therapeutic options for childhood inflammatory bowel disease

February 24, 2022
  • 4
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 5

Sponsors

Sponsors fund meetings of the expert group and pay for the services of E4H to provide secretariat support to the group. Sponsors have no editorial control over the content of expert group materials except for reviewing the materials to ensure compliance with industry codes of ethical conduct.

Website owned and developed by E4H
Privacy Policy | Terms & Conditions